December 6th 2023
What neuromodulation can be used to specifically target nicotine users with schizophrenia? This research may tell us.
December 5th 2023
Deep brain stimulation for substance use disorders when everything else fails, the history of the ACNP, and more.
Research presented at the ACNP 2023 Annual Meeting shows that neuromodulation therapy cTBS could be a viable schizophrenia-specific intervention for nicotine use.
November 21st 2023
In this CME, review the risks and clinical implications of intimate partner violence on women’s substance use and treatment.
November 14th 2023
Young men appear to be particularly susceptible to the effects of cannabis on schizophrenia.
Substance Use Disorders Research Roundup: November 3, 2023
What is new in research on SUDs?
Cannabis, Psychosis, and the Legal Implications: Chicken or Egg?
Explore the relationship between cannabis use and psychosis.
A New Draft Guide for Developing Stimulant Use Disorder Treatments
The FDA has released a draft guide to offer their perspective and thoughts on the development of treatments for stimulant use disorder.
The Week in Review: September 18-22
From violence risk assessment in emergency departments to connections between bipolar disorder and substance use disorders, here are highlights from the week in Psychiatric Times.
How Do Treatments for Bipolar Disorder and SUD Affect One Another?
An expert discusses the connections between the 2 highly comorbid diseases and some ways to effectively treat both diseases simultaneously.
Acknowledging International Overdose Awareness Day
Today is International Overdose Awareness Day!
Study Shows That Anti-Fentanyl Antibody Reverses Signs of Carfentanil Overdose
“We expect this antibody to be a valuable new weapon for fighting the opioid crisis.”
From the Pages of Psychiatric Times: July 2023
The experts weighed in on a wide variety of psychiatric issues for the July 2023 issue of Psychiatric Times.
The Week in Review: July 17-21
From a look at adolescent substance use to special challenges in treating borderline personality disorder during the perinatal period, here are highlights from the week in Psychiatric Times.
Adolescent Substance Use: Reasons for Optimism and Concern
"Although adolescent substance use is a topic that can be challenging for families and clinicians alike, data demonstrate that interventions during this time are effective for preventing, identifying, and reducing risky use."
Fentanyl: Accelerant of the Adolescent Opioid Crisis
How can we turn the tide of the fentanyl epidemic?
Continued Cannabis Confusion
Should cannabis be regulated in the United States in a manner similar to alcohol and tobacco?
The Week in Review: June 5-9
From adherence in addiction recovery treatment to the relationship between social media use and youth mental health, here are highlights from the week in Psychiatric Times.
Adherence in Addiction Recovery Treatment: Surrender is Scary, Yet Critical
Here’s how you can effectively encourage treatment adherence when helping patients with substance use disorder.
The Week in Review: May 29-June 2
From substance use among adolescents and young adults to managing behavioral and psychological symptoms of dementia, here are highlights from the week in Psychiatric Times.
Substance Use Among Adolescents and Young Adults
In this CME, check out best practices for screening and treating adolescents and young adults with substance use issues.
Teach and Treat Your Children Well
"It is essential to have an aggressive path forward to increase public awareness of mental health and illness, education on early intervention and treatment access, and continued destigmatization of mental illness."
Everything You Need to Know When Referring Patients to Ketamine Therapy Clinics
Ketamine is relatively new to the average American. What can you share with them as a mental health clinician?
The Week in Review: May 1-5
From new FDA treatment approvals to choosing the right levels of care in crisis stabilization units, here are highlights from the week in Psychiatric Times.
An Imperfect Guide to Crisis Stabilization Units: Matching the Right Level of Care to Individual Needs
Here’s how having a clear understanding of the services different crisis stabilization units provide can help communities serve the unique needs of each individual in crisis without unnecessarily restrictive or intensive levels of care.
From the Pages of Psychiatric Times: April 2023
The experts weighed in on a wide variety of psychiatric issues for the April 2023 issue of Psychiatric Times.
The Week in Review: April 10-14
From to co-occurring substance use and eating disorders to treatment options for OCD, here are highlights from the week in Psychiatric Times.
New SAMHSA CCBHC Criteria Will Foster Innovation in Crisis Services Continuum
The new criteria have been updated to increase flexibility and provide greater clarity around standards for behavioral health clinicians.
Co-occurring Substance Use and Eating Disorders
What does existing research say about the connection between substance use disorders and eating disorders?
The Week in Review: April 3-7
From over-the-counter naloxone to the true connection between gun violence and mental illness, here are highlights from the week in Psychiatric Times.
Over-the-Counter Naloxone: A Step in the Right Direction?
Psychiatric Times’ Substance Use Section Editor weighs in on the FDA approval of the first naloxone product for nonprescription use.
The Week in Review: March 27-31
From gut microbiota and SSRIs in MDD to nonpharmacological interventions following TBI, here are highlights from the week in Psychiatric Times.
FDA Approves First Naloxone Product for Over-the-Counter Use
The AMA, substance abuse experts share their thoughts on this decision and what it means for psychiatric clinicians and their patients.
Thoughts About the Overdose Conundrum
One doctor’s experience with patient suicide.
The “Unwinding” of the Medicaid Continuous Enrollment Condition: 3 Things to Know
Patients with serious mental illness and substance use disorders are expected to be particularly affected by these changes.
2 Clarke Drive Cranbury, NJ 08512